Clinical Trials Browser

Completed × Alpelisib × Tumor-Agnostic × Clear all

NCT01870505 2024-12-09

BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer

Phase 1 Completed

52 enrolled 19 charts

Neoplasm Metastasis